Skip to main content
Top
Published in: Addiction Science & Clinical Practice 1/2015

Open Access 01-12-2015 | Meeting abstract

The Vivitrol pilot program (VPP): initial quantitative findings from an extended-release naltrexone study

Authors: Traci Rieckmann, Katherine T Garvey, Priya Srikanth, Laura Andrich, Jessica Gregg

Published in: Addiction Science & Clinical Practice | Special Issue 1/2015

Login to get access

Excerpt

In 2010, the FDA approved the use of extended-release injectable naltrexone (Vivitrol©) for the treatment of opioid dependence. Preliminary evidence from prior studies indicates that monthly injections of Vivitrol are effective in treating opioid dependence after initial detoxification. This longitudinal exploratory study measures demographics, medication adherence, sobriety (urinalysis), utilization of care, and mental and emotional states in patients who were treated for opioid dependence with injectable naltrexone at an addictions stabilization center. …
Metadata
Title
The Vivitrol pilot program (VPP): initial quantitative findings from an extended-release naltrexone study
Authors
Traci Rieckmann
Katherine T Garvey
Priya Srikanth
Laura Andrich
Jessica Gregg
Publication date
01-12-2015
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1940-0640-10-S1-A54

Other articles of this Special Issue 1/2015

Addiction Science & Clinical Practice 1/2015 Go to the issue